Kalina Scott, Chief Financial Officer. She joined from Bank am Bellevue in Zurich, where she was Managing Director Corporate Finance, responsible for transactions in the fields of mergers & acquisitions, capital markets and private placements. A seasoned professional with 20 years of work experience in investment banking and corporate finance, she started her career at UBS in Zurich and London, working in structured finance and credit risk management, followed by leveraged finance as well as mergers & acquisitions. As Director of Corporate Finance at KPMG Zurich, she successfully created a corporate defense offering and supported the IPO advisory business of KPMG. Overall she has executed corporate finance transactions for more than 20 renown companies – including the IPOs of Investis, Cassiopea, Molecular Partners, and more recently Galenica Santé, as well as strategic transactions for Berna Biotech, Sulzer Medica, Mathys Medical and the Hirslanden group. Kalina Scott studied Business and Economics at the University of Leipzig, Germany, and is a Bachelor of Business Administration of the Sofia University in Bulgaria.